35 / 74 · 0:54 · Original AXON film
AICAR
The burned-in captions and transcript carry the scientific claims and their limitations. The visuals are conceptual illustrations, not validated molecular models or experimental images. The video has no voice or audio. The full explanation is visible on screen; optional accessible captions are available in the player.
Read every result in its study context. A cell experiment, animal model, exploratory analysis and controlled human trial answer different questions.
Prepared 05 November 2026. Regulatory status is jurisdiction- and date-specific. No claim of specialist review or exhaustive evidence coverage.
Transcript
AICAR | A nucleoside analogue
AICAR often appears beside peptides, but the riboside studied here is a nucleoside analogue. Researchers use it to investigate cellular energy-sensing pathways. [1] [2]
MOUSE STUDY | 2008
A widely cited 2008 study linked AICAR treatment with AMPK-related metabolic changes and increased running endurance in sedentary mice. The species is essential to the finding. [1]
One test does not reproduce exercise
A laboratory endurance test captures one outcome under controlled conditions. It does not show that AICAR reproduces the many health effects of exercise in people. [1]
Mechanism first | Clinical evidence separately
The useful takeaway is the research question: how does energy sensing affect muscle metabolism? Human benefit and safety require direct evidence for the intended use. [1]
Sources and context
These linked sources support the evidence distinctions in this short overview. This is not a systematic review, endorsement or treatment recommendation.
- Narkar et al. (2008): AMPK and PPARdelta agonists are exercise mimetics →The AICAR endurance result was in mice; the paper title is not a human clinical conclusion.
- Synthesis of 5-Aminoimidazole-4-Carboxamide Riboside (AICAR) and Its Derivatives Using Inosine as Starting Material (2015) →Chemical identity of the riboside; no synthetic procedure is reproduced.
